RAPT Therapeutics (RAPT) Capital Expenditures (2020 - 2024)
Historic Capital Expenditures for Therapeutics (RAPT) over the last 5 years, with Q4 2024 value amounting to $1000.0.
- Therapeutics' Capital Expenditures fell 9850.75% to $1000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $122000.0, marking a year-over-year decrease of 8915.56%. This contributed to the annual value of $122000.0 for FY2024, which is 8915.56% down from last year.
- As of Q4 2024, Therapeutics' Capital Expenditures stood at $1000.0, which was down 9850.75% from $17000.0 recorded in Q3 2024.
- In the past 5 years, Therapeutics' Capital Expenditures ranged from a high of $759000.0 in Q1 2023 and a low of -$1000.0 during Q2 2024
- Its 5-year average for Capital Expenditures is $170789.5, with a median of $98000.0 in 2020.
- Per our database at Business Quant, Therapeutics' Capital Expenditures skyrocketed by 78437.5% in 2022 and then crashed by 10042.92% in 2024.
- Quarter analysis of 5 years shows Therapeutics' Capital Expenditures stood at $174000.0 in 2020, then surged by 126.44% to $394000.0 in 2021, then crashed by 87.56% to $49000.0 in 2022, then surged by 36.73% to $67000.0 in 2023, then tumbled by 98.51% to $1000.0 in 2024.
- Its last three reported values are $1000.0 in Q4 2024, $17000.0 for Q3 2024, and -$1000.0 during Q2 2024.